ArticleTanaffos2024
Investigating Sleep Disorders among Patients Suffering from Pulmonary Arterial Hypertension.
Article in Tanaffos, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary arterial hypertension (PAH) is a progressive and fatal disease. Studies have shown a link between sleep disorders and pulmonary hypertension; however, sleep disorders generally remain undiagnosed. This study aimed to investigate the types of sleep disorders and their prevalence among patients with pulmonary hypertension. Materials and Methods: A total of 68 patients with a definitive diagnosis of pulmonary hypertension were examined for the existence of sleep disorders. The STOP-BANG, ISI, ESS, RLS, and parasomnia questionnaires were used to evaluate sleep disorders, including obstructive sleep apnea, insomnia, excessive sleepiness, and movement disorders, such as restless leg syndrome and parasomnia, respectively. The data were analyzed using SPSS software. Results: The average age of the patients was 48.0 ± 14.2 years while 64.7% were women. The most prevalent (45.6%) sleep disorder among the patients was probable obstructive sleep apnea (STOP-BANG positive). Among STOP-BANG positive and negative groups, the ratios of men were 48.4% and 24.3%, respectively (P=0.046). In addition, there was a significant difference between STOP-BANG positive and negative groups regarding the variables of gender, age, having high systemic blood pressure, insomnia index, and daytime sleepiness (P values= 0.020, 0.046, 0.011, 0.023, and 0.011, respectively). The prevalence of parasomnia (P= 0.039) and daytime sleepiness (P=0.072) was significantly higher in people suffering from insomnia. The body mass index was significantly higher in people with idiopathic pulmonary hypertension than in those with thromboembolic pulmonary hypertension (P= 0.001). There was a significant association between age and the functional class of the patients (P= 0.003). Conclusion: The prevalence of sleep disorders, especially obstructive sleep apnea, is relatively high in patients with PAH, and its presence seems to worsen the prognosis of PAH necessitating identifying at-risk people and properly treating them to improve their quality of life.
Indexed as
Identifiers
40704339PMC12281350What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.